Sagar Cements Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Sagar Cements wird ein jährliches Gewinn- und Umsatzwachstum von 99% bzw. 14.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 101.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 5.1% betragen.
Wichtige Informationen
99.0%
Wachstumsrate der Gewinne
101.5%
EPS-Wachstumsrate
Basic Materials Gewinnwachstum | 16.9% |
Wachstumsrate der Einnahmen | 14.4% |
Zukünftige Eigenkapitalrendite | 5.1% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 27 Oct 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Time To Worry? Analysts Are Downgrading Their Sagar Cements Limited (NSE:SAGCEM) Outlook
Oct 27Market Might Still Lack Some Conviction On Sagar Cements Limited (NSE:SAGCEM) Even After 27% Share Price Boost
Jul 05Shareholders Will Probably Not Have Any Issues With Sagar Cements Limited's (NSE:SAGCEM) CEO Compensation
Jun 20Sagar Cements (NSE:SAGCEM) Has Affirmed Its Dividend Of ₹0.70
Jun 06Investors Aren't Entirely Convinced By Sagar Cements Limited's (NSE:SAGCEM) Revenues
Mar 12Sagar Cements Limited's (NSE:SAGCEM) Intrinsic Value Is Potentially 43% Above Its Share Price
Jan 02An Intrinsic Calculation For Sagar Cements Limited (NSE:SAGCEM) Suggests It's 40% Undervalued
Aug 05Sagar Cements (NSE:SAGCEM) Is Paying Out A Dividend Of ₹0.70
May 28These 4 Measures Indicate That Sagar Cements (NSE:SAGCEM) Is Using Debt In A Risky Way
Dec 02Does Sagar Cements (NSE:SAGCEM) Have A Healthy Balance Sheet?
Feb 25Should You Be Adding Sagar Cements (NSE:SAGCEM) To Your Watchlist Today?
Jan 26Returns Are Gaining Momentum At Sagar Cements (NSE:SAGCEM)
Aug 04Here's Why I Think Sagar Cements (NSE:SAGCEM) Might Deserve Your Attention Today
Jul 22Is Sagar Cements Limited (NSE:SAGCEM) Trading At A 38% Discount?
Jun 20Is Sagar Cements Limited (NSE:SAGCEM) A Risky Dividend Stock?
May 11Is It Too Late To Consider Buying Sagar Cements Limited (NSE:SAGCEM)?
Apr 12Is There An Opportunity With Sagar Cements Limited's (NSE:SAGCEM) 49% Undervaluation?
Mar 18Is Now The Time To Put Sagar Cements (NSE:SAGCEM) On Your Watchlist?
Mar 07Is Sagar Cements (NSE:SAGCEM) A Future Multi-bagger?
Feb 21Sagar Cements (NSE:SAGCEM) Has A Pretty Healthy Balance Sheet
Feb 09Here's Why We're Wary Of Buying Sagar Cements' (NSE:SAGCEM) For Its Upcoming Dividend
Jan 28Sagar Cements Limited (NSE:SAGCEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Jan 22Know This Before Buying Sagar Cements Limited (NSE:SAGCEM) For Its Dividend
Jan 18Insider Buying: The Sagar Cements Limited (NSE:SAGCEM) Chief Financial Officer Just Bought 30% More Shares
Dec 28Sagar Cements's (NSE:SAGCEM) Earnings Are Growing But Is There More To The Story?
Dec 18Do Its Financials Have Any Role To Play In Driving Sagar Cements Limited's (NSE:SAGCEM) Stock Up Recently?
Dec 07Is It Time To Consider Buying Sagar Cements Limited (NSE:SAGCEM)?
Nov 22Is Sagar Cements (NSE:SAGCEM) A Risky Investment?
Nov 10Upgrade: Analysts Just Made A Captivating Increase To Their Sagar Cements Limited (NSE:SAGCEM) Forecasts
Oct 26Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
3/31/2027 | 33,687 | 1,061 | 2,943 | 5,253 | 5 |
3/31/2026 | 29,643 | 136 | 1,560 | 4,195 | 8 |
3/31/2025 | 24,330 | -1,157 | 581 | 2,663 | 6 |
9/30/2024 | 24,138 | -788 | 1,659 | 3,305 | N/A |
6/30/2024 | 25,255 | -319 | N/A | N/A | N/A |
3/31/2024 | 25,046 | -434 | 1,746 | 4,004 | N/A |
12/31/2023 | 24,174 | 337 | N/A | N/A | N/A |
9/30/2023 | 23,238 | 230 | 883 | 2,731 | N/A |
6/30/2023 | 22,115 | -35 | N/A | N/A | N/A |
3/31/2023 | 22,295 | 302 | 574 | 1,752 | N/A |
12/31/2022 | 21,097 | -830 | N/A | N/A | N/A |
9/30/2022 | 18,676 | -505 | -1,423 | 559 | N/A |
6/30/2022 | 17,620 | 120 | N/A | N/A | N/A |
3/31/2022 | 15,969 | 692 | -2,740 | 870 | N/A |
12/31/2021 | 15,128 | 1,278 | N/A | N/A | N/A |
9/30/2021 | 15,428 | 1,721 | -2,759 | 2,798 | N/A |
6/30/2021 | 14,998 | 2,013 | N/A | N/A | N/A |
3/31/2021 | 13,713 | 1,865 | -841 | 3,765 | N/A |
12/31/2020 | 12,572 | 1,374 | N/A | N/A | N/A |
9/30/2020 | 11,557 | 786 | 48 | 2,328 | N/A |
6/30/2020 | 10,951 | 333 | N/A | N/A | N/A |
3/31/2020 | 11,752 | 267 | -258 | 2,021 | N/A |
12/31/2019 | 12,374 | 442 | N/A | N/A | N/A |
9/30/2019 | 12,944 | 503 | N/A | N/A | N/A |
6/30/2019 | 12,869 | 373 | N/A | N/A | N/A |
3/31/2019 | 12,176 | 136 | -624 | 1,330 | N/A |
12/31/2018 | 11,466 | -4 | N/A | N/A | N/A |
9/30/2018 | 10,769 | 56 | N/A | N/A | N/A |
6/30/2018 | 10,542 | 221 | N/A | N/A | N/A |
3/31/2018 | 10,381 | 263 | N/A | 1,499 | N/A |
12/31/2017 | 9,773 | 184 | N/A | N/A | N/A |
9/30/2017 | 9,192 | 148 | N/A | N/A | N/A |
6/30/2017 | 8,752 | 63 | N/A | N/A | N/A |
3/31/2017 | 8,138 | -39 | N/A | 1,010 | N/A |
12/31/2016 | 8,625 | 108 | N/A | N/A | N/A |
9/30/2016 | 7,846 | 143 | N/A | N/A | N/A |
6/30/2016 | 7,637 | 230 | N/A | N/A | N/A |
3/31/2016 | 7,534 | 443 | N/A | 1,289 | N/A |
12/31/2015 | 6,883 | 562 | N/A | N/A | N/A |
9/30/2015 | 6,908 | 543 | N/A | N/A | N/A |
6/30/2015 | 6,350 | 3,279 | N/A | N/A | N/A |
3/31/2015 | 5,756 | 2,967 | N/A | 270 | N/A |
12/31/2014 | 5,316 | 2,636 | N/A | N/A | N/A |
9/30/2014 | 5,251 | 2,541 | N/A | N/A | N/A |
6/30/2014 | 5,012 | -295 | N/A | N/A | N/A |
3/31/2014 | 4,889 | -256 | N/A | 475 | N/A |
12/31/2013 | 4,933 | -185 | N/A | N/A | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: SAGCEM wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (6.7%).
Ertrag vs. Markt: SAGCEM wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: SAGCEM wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: SAGCEMDie Einnahmen des Unternehmens (14.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.4% pro Jahr).
Hohe Wachstumseinnahmen: SAGCEMDie Einnahmen des Unternehmens (14.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: SAGCEMDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (5.1%).